documents: FDA-2017-D-5928-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-5928-0001 FDA FDA-2017-D-5928 Post-Complete Response Letter Meetings Between the Food and Drug Administration and Abbreviated New Drug Application Applicants Under the Generic Drug User Fee Act; Draft Guidance for Industry; Availability Notice Notice of Availability 2017-10-16T04:00:00Z 2017 10 2017-10-16T04:00:00Z 2017-12-16T04:59:59Z 2017-12-16T02:02:44Z 2017-22288 0 0 0900006482bcd99e

Links from other tables